secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2024-01-02T23:59:59+00:00
Accession:  0001213900-24-000056
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics announces 1-for-10 reverse stock split effective Jan 4, 2024
--------------------------------------------------------------------------------

- Reverse split ratio set at 1-for-10, effective 12:01 a.m. ET on Jan 4, 2024.
- Outstanding shares reduced from ~111.6M to ~11.2M; par value unchanged.
- Intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- No fractional shares; cash in lieu based on Jan 3 closing price.
- Warrants adjusted: 10 warrants exercisable for 1 share at $115.00 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/0001213900-24-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/ea190805-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer